Answers are grounded in this paper and cite their sources.
Assesses therapeutic effectiveness and safety in individuals with treatment-resistant OCD and MDD, suggesting potential for novel intervention.
The aim is to systematically assess the therapeutic effectiveness and safety of MRgFUS in individuals with refractory obsessive–compulsive disorder (OCD) and major depressive disorder (MDD).
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: